Immunovia AB (publ) (IMMVF)
USD 0.07
(0.0%)
USD 0.07
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 291.5 Million SEK | 54.94% |
| 2022 | 188.14 Million SEK | 3.06% |
| 2021 | 182.55 Million SEK | 4.28% |
| 2020 | 175.06 Million SEK | 23.79% |
| 2019 | 141.42 Million SEK | 24.47% |
| 2018 | 113.61 Million SEK | 62.85% |
| 2017 | 69.76 Million SEK | 76.72% |
| 2016 | 39.48 Million SEK | 61.6% |
| 2015 | 24.43 Million SEK | 157.34% |
| 2014 | 9.49 Million SEK | 240.0% |
| 2013 | 2.79 Million SEK | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 23.99 Million SEK | -1.32% |
| 2024 Q1 | 24.31 Million SEK | 2.51% |
| 2023 Q3 | 39.23 Million SEK | -78.2% |
| 2023 Q4 | 23.71 Million SEK | -39.55% |
| 2023 FY | 291.5 Million SEK | 54.94% |
| 2023 Q1 | 48.56 Million SEK | -4.25% |
| 2023 Q2 | 179.99 Million SEK | 270.64% |
| 2022 Q3 | 40.81 Million SEK | -18.87% |
| 2022 Q2 | 50.31 Million SEK | 8.67% |
| 2022 Q1 | 46.29 Million SEK | -8.21% |
| 2022 FY | 188.14 Million SEK | 3.06% |
| 2022 Q4 | 50.71 Million SEK | 24.25% |
| 2021 Q1 | 39.91 Million SEK | -17.27% |
| 2021 Q3 | 37.64 Million SEK | -31.01% |
| 2021 Q2 | 54.56 Million SEK | 36.69% |
| 2021 FY | 182.55 Million SEK | 4.28% |
| 2021 Q4 | 50.43 Million SEK | 33.99% |
| 2020 Q1 | 43.39 Million SEK | 14.64% |
| 2020 Q2 | 39.85 Million SEK | -8.17% |
| 2020 Q3 | 43.56 Million SEK | 9.32% |
| 2020 Q4 | 48.24 Million SEK | 10.74% |
| 2020 FY | 175.06 Million SEK | 23.79% |
| 2019 Q4 | 37.85 Million SEK | 9.83% |
| 2019 Q1 | 33.2 Million SEK | 5.99% |
| 2019 Q3 | 34.46 Million SEK | -3.98% |
| 2019 Q2 | 35.89 Million SEK | 8.1% |
| 2019 FY | 141.42 Million SEK | 24.47% |
| 2018 Q2 | 34.15 Million SEK | 42.2% |
| 2018 Q1 | 24.02 Million SEK | 0.63% |
| 2018 Q3 | 24.16 Million SEK | -29.26% |
| 2018 Q4 | 31.32 Million SEK | 29.65% |
| 2018 FY | 113.61 Million SEK | 62.85% |
| 2017 Q2 | 16.27 Million SEK | 21.09% |
| 2017 Q3 | 16.18 Million SEK | -0.57% |
| 2017 Q4 | 23.87 Million SEK | 47.52% |
| 2017 FY | 69.76 Million SEK | 76.72% |
| 2017 Q1 | 13.44 Million SEK | 4.21% |
| 2016 Q4 | 12.89 Million SEK | 39.84% |
| 2016 Q3 | 9.22 Million SEK | -5.19% |
| 2016 Q2 | 9.72 Million SEK | 27.48% |
| 2016 Q1 | 7.63 Million SEK | 211.75% |
| 2016 FY | 39.48 Million SEK | 61.6% |
| 2015 Q2 | 1.33 Million SEK | 0.0% |
| 2015 Q3 | 2.44 Million SEK | 83.29% |
| 2015 Q4 | 2.44 Million SEK | 0.0% |
| 2015 FY | 24.43 Million SEK | 157.34% |
| 2015 Q1 | 1.33 Million SEK | 70.83% |
| 2014 Q4 | 781.75 Thousand SEK | 0.0% |
| 2014 FY | 9.49 Million SEK | 240.0% |
| 2014 Q1 | 235.55 Thousand SEK | 0.0% |
| 2014 Q2 | 235.55 Thousand SEK | 0.0% |
| 2014 Q3 | 781.75 Thousand SEK | 231.87% |
| 2013 FY | 2.79 Million SEK | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Bio Medica Corporation | 1.04 Million USD | -27689.133% |
| Arrayit Corporation | 6.19 Million USD | -4603.581% |
| Atlantic International Corp. | 5.57 Million USD | -5125.773% |
| Biocept, Inc. | 29.4 Million USD | -891.49% |
| Bioqual, Inc. | 7.44 Million USD | -3813.505% |
| CardioGenics Holdings Inc | 772.14 Thousand USD | -37653.159% |
| DermTech, Inc. | 104.01 Million USD | -180.256% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 166.5 Million USD | -75.079% |
| HTG Molecular Diagnostics, Inc. | 22.62 Million USD | -1188.508% |
| iMD Companies, Inc. | 151.8 Thousand USD | -191922.871% |
| IDenta Corp. | 662.97 Thousand USD | -43869.682% |
| Interpace Biosciences, Inc. | 20.23 Million USD | -1340.826% |
| Integrative Health Technologies, Inc. | 38.88 Thousand USD | -749644.091% |
| InVitro International | 661.32 Thousand USD | -43979.453% |
| Lumos Diagnostics Holdings Limited | 7.09 Million USD | -4006.903% |
| Many Bright Ideas Technologies Inc. | 58.11 Thousand USD | -501531.333% |
| Medical Imaging Corp. | 1.91 Million USD | -15144.927% |
| NovelStem International Corp. | 3.53 Million USD | -8139.812% |
| Optigenex Inc. | 1.28 Million USD | -22534.911% |
| PharmChem, Inc. | 2.93 Million USD | -9844.907% |
| Proteome Sciences plc | 3.26 Million USD | -8820.073% |
| Response Genetics, Inc | 25.31 Million USD | -1051.341% |
| Rennova Health, Inc. | 7.67 Million USD | -3696.772% |
| RushNet, Inc. | 1.78 Million USD | -16191.552% |
| ScreenPro Security Inc. | 3.23 Million USD | -8900.18% |
| Stella Diagnostics Inc. | 11.42 Million USD | -2451.057% |
| StageZero Life Sciences Ltd. | 7.34 Million USD | -3869.867% |
| Todos Medical Ltd. | 14.05 Million USD | -1973.609% |